Clinical Trial

Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine

Study acronym: GTSEM
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn whether Gou-Teng-San (GTS), a traditional herbal medicine, is effective and safe for adults with episodic migraine. In this double-blind randomized controlled trial, participants with episodic migraine will be assigned by chance to a study treatment group. The study will evaluate whether GTS can reduce migraine frequency, improve migraine-related symptoms, and lessen the impact of migraine on daily life. Researchers will also monitor safety and tolerability throughout the study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-22.
Trial Details
NCT Number NCT07496034
Lead Sponsor Tsai, Chueh-Yi, MD
Collaborators: Chung Shan Medical University, China Medical University, Taiwan
Conditions Episodic Migraine
Enrollment 40 participants
Start Date 2025-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-20